Skip to content

In the BioHarmony Drug Report Database

Ceftolozane

Zerbaxa (ceftolozane) is a small molecule pharmaceutical. Ceftolozane was first approved as Zerbaxa on 2014-12-19. It is used to treat bacterial infections, bacteroides infections, escherichia coli infections, intraabdominal infections, and klebsiella infections amongst others in the USA. It has been approved in Europe to treat bacterial infections. Zerbaxa's patents are valid until 2035-08-14 (FDA).
Trade Name Zerbaxa
Common Name Ceftolozane
Indication bacterial infections, bacteroides infections, escherichia coli infections, intraabdominal infections, klebsiella infections, proteus infections, pseudomonas infections, streptococcal infections, urinary tract infections
Drug Class Cephalosporins
Ceftolozane
Get full access now